Literature DB >> 26259625

Asymmetric AB3 Miktoarm Star Polymers: Synthesis, Self-Assembly, and Study of Micelle Stability Using AF4 for Efficient Drug Delivery.

Alexandre Moquin1, Anjali Sharma2, Yiming Cui1, Anthony Lau2, Dusica Maysinger3, Ashok Kakkar4.   

Abstract

A simple and versatile methodology, which employs a combination of ring-opening polymerization and alkyne-azide click chemistry to synthesize amphiphilic AB3 miktoarm stars, is reported. Their aqueous self-assembly behavior was studied using dynamic light scattering, fluorescence, and asymmetrical flow field-flow fractionation (AF4). AB3 miktoarm stars form micelles which incorporate curcumin with high efficiency, and significantly reduce the viability of glioblastoma cells in spheroids. We demonstrate that AF4 is an effective technique to determine the size distribution of self-assembled structures exposed to a biological medium. The ease, with which asymmetric AB3 miktoarm polymers are constructed, provides a platform that can be widely employed to deliver a variety of lipophilic drugs.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  amphiphilic miktoarm star polymer; drug delivery systems; field-flow fractionation; glioblastoma spheroids; micelles

Mesh:

Substances:

Year:  2015        PMID: 26259625     DOI: 10.1002/mabi.201500186

Source DB:  PubMed          Journal:  Macromol Biosci        ISSN: 1616-5187            Impact factor:   4.979


  2 in total

Review 1.  Asymmetric flow field-flow fractionation as a multifunctional technique for the characterization of polymeric nanocarriers.

Authors:  Federico Quattrini; Germán Berrecoso; José Crecente-Campo; María José Alonso
Journal:  Drug Deliv Transl Res       Date:  2021-01-31       Impact factor: 4.617

2.  In Vitro and In Vivo Studies on HPMA-Based Polymeric Micelles Loaded with Curcumin.

Authors:  Mahsa Bagheri; Marcel H Fens; Tony G Kleijn; Robin B Capomaccio; Dora Mehn; Przemek M Krawczyk; Enzo M Scutigliani; Andrei Gurinov; Marc Baldus; Nicky C H van Kronenburg; Robbert J Kok; Michal Heger; Cornelus F van Nostrum; Wim E Hennink
Journal:  Mol Pharm       Date:  2021-01-19       Impact factor: 4.939

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.